Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Organizing biological data
Hepacivirus hominis
HCV genetic variability: its implication for both viral translational efficiency and resistance to direct antivirals
Transcriptome of hepatitis C virus (JFH-1 strain)-infected Huh7 cells
CERI-KRISP Hepatitis C Virus sequencing in South Africa
Cytokine profile and viral diversity in the early seronegative stage of community-acquired hepatitis C virus (HCV) infection
Fitness-dependent, mild mutagenic activity of sofosbuvir for hepatitis C virus
Nano-DMS-MaP allows isoform specific RNA structure determination
Metagenomics-M37
Quasispecies fitness partition to characterize the molecular status of a viral population. Negative effect of early ribavirin discontinuation in a chronically infected HEV patient
Detection of Resistance Associated Substitutions to NS5A Inhibitors in a Group of Drug Users in Portugal
HCV HVR1
Resistance aResistance associated substitutions in relapse patients of chronic hepatitis C infection treated with direct acting antivi
CD8+ T-cell exhaustion phenotype in chronic hepatitis C virus infection is associated with epitope sequence variation
HCV Ministry of Health BRAZIL
Intra-host analysis of hepaciviral glycoprotein evolution reveals signatures associated with viral persistence and clearance
HCV - MS - BRASIL
Frequent transition mutation of hepatitis C virus in patients with chronic hepatitis C determined by single molecule real-time sequencing.
Serum virome analysis in patients with liver diseases
Hepacivirus hominis strain:A106 | isolate:A106
Hepacivirus hominis strain:A106 | isolate:A106 Raw sequence reads
Difference of intra-host dynamics of the second human pegivirus (HPgV-2) and hepatitis C virus (HCV) in HPgV-2/HCV co-infected patients
Late relapse and reinfection in HCV patients treated with direct-acting antiviral (DAA) drugs
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on